Ignite Creation Date:
2024-07-17 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466122
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-07
Brief Title:
Pirtobrutinib LOXO-305 and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
Sponsor:
Kerry Rogers
Organization:
Ohio State University Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Lymphocytic Leukemia |
| Small Lymphocytic Lymphoma |
Keywords: